Literature DB >> 34141040

Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis.

Brad E Schwartz1, Karen Keller Baker1, Andrew J Bleinberger2, Amina Lleshi2, Raul Cruz-Cano3.   

Abstract

Entities:  

Year:  2021        PMID： 34141040      PMCID： PMC8188283          DOI： 10.5847/wjem.j.1920-8642.2021.03.012

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN： 1920-8642


× No keyword cloud information.
  17 in total

1.  A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.

Authors:  H Lal; G Gianutsos; S K Puri
Journal:  Life Sci       Date:  1975-07-01       Impact factor: 5.037

2.  Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer.

Authors:  R M Cole; F Robinson; L Harvey; K Trethowan; V Murdoch
Journal:  J Pain Symptom Manage       Date:  1994-01       Impact factor: 3.612

3.  Haloperidol Versus Ondansetron for Treatment of Established Nausea and Vomiting Following General Anesthesia: A Randomized Clinical Trial.

Authors:  Vanda G Yazbeck-Karam; Sahar M Siddik-Sayyid; Hanane B Barakat; Serge Korjian; Marie T Aouad
Journal:  Anesth Analg       Date:  2017-02       Impact factor: 5.108

Review 4.  The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?

Authors:  Carla Meyer-Massetti; Christine M Cheng; Bradley A Sharpe; Christoph R Meier; B Joseph Guglielmo
Journal:  J Hosp Med       Date:  2010-04       Impact factor: 2.960

5.  Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department.

Authors:  Rene Ramirez; Philip Stalcup; Brandon Croft; Michael A Darracq
Journal:  Am J Emerg Med       Date:  2017-03-12       Impact factor: 2.469

6.  Is low-dose haloperidol a useful antiemetic?: A meta-analysis of published and unpublished randomized trials.

Authors:  Michael Büttner; Bernhard Walder; Erik von Elm; Martin R Tramèr
Journal:  Anesthesiology       Date:  2004-12       Impact factor: 7.892

7.  Randomized Controlled Double-blind Trial Comparing Haloperidol Combined With Conventional Therapy to Conventional Therapy Alone in Patients With Symptomatic Gastroparesis.

Authors:  Carlos J Roldan; Kimberly A Chambers; Linda Paniagua; Sonali Patel; Marylou Cardenas-Turanzas; Yashwant Chathampally
Journal:  Acad Emerg Med       Date:  2017-07-26       Impact factor: 3.451

Review 8.  Narcotic bowel syndrome.

Authors:  Adam D Farmer; Jayne Gallagher; Caroline Bruckner-Holt; Qasim Aziz
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-03-06

9.  Haloperidol for treatment of cannabinoid hyperemesis syndrome.

Authors:  Jami L Hickey; Joanne C Witsil; Mark B Mycyk
Journal:  Am J Emerg Med       Date:  2013-04-10       Impact factor: 2.469

10.  Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.

Authors:  Jeff Lapoint; Seth Meyer; Charles K Yu; Kristi L Koenig; Roneet Lev; Sayone Thihalolipavan; Katherine Staats; Christopher A Kahn
Journal:  West J Emerg Med       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.